1. PURPOSE OF EXAMINATION: To lay down the procedure Toluidine blue staining in Histo-pathology section at NCHLS Surat.
2. PRINCIPLE AND METHOD OF PROCEDURE USED FOR EXAMINATION: when tissue is stained with Toluidine blue stain it gives rise orthochromatic blue color to amyloid deposits.
3. STAFF RESPONSIBLE: lab. Technician under supervision of resident doctor/tutor.
5. TYPE OF SAMPLE: Histopathology section slide
6. PATIENTS PREPARATIONS: NA
7. TYPE OF CONTAINERS AND ADDITIVES:
8. POSITIVE CONTROL: Amyloidosis.
9. REQUIRED EQUIPMENTS AND REAGENTS:
EQUIPMENTS: Clean labelled containers, Coplin jars.
REAGENT: 1% Toluidine blue, 50% isopropyle alcohol, absolute alcohol, Xylene, DPX.
10. ENVIRONMENTAL AND SAFETY CONTROLS: Universal safety precautions
11. CALIBRATION PROCEDURE (METROLOGICAL TRACEBILITY):NA
12. PROCEDURE(STEPS):
REAGENT preparation-
1gm Toluidine blue in 100ml of 50% isopropanol.
Staining procedure:
• Take test slide on which staining has to be performed along with positive control.
• Deparaffinize section by keeping in oven for 5min and clear it with 2 changes of xylene each for 15 minute.
• Bring section to water.
• Stain in freshly prepared 1% Toluidine blue in 50% isopropyle alcohol for 30 minute at 37C.
• Blot with tissue paper and place in a isopropyle alcohol for 1 minute.
• Dehydrate in alcohol, clear in xylene, mount with DPX
Result
• Amyloid: orthochromatic blue.
13. QUALITY CONTROL PROCEDURE: The newer batch of stain is tested before being put in to use by checking their efficiency with the batch of stain already in use.
14. INTERFERENCE: Inadequate quality/improper dilution
15. PRINCIPLE OF PROCEDURE FOR CALCULATING RESULTS INCLUDING, WHERE RELEVENT, THE MEASUREMENT OF UNCERTAINITY OF MEASURED QUANTITY VALUES:NA
16. BIOLOGICAL REFERENCE INTERVALS OR CLINICAL DECISION VALUES:NA
17. REPORTABLE INTERVAL OF EXAMINATION RESULTS: NA
18. INSTRUCTION FOR DETERMINING QUANTITATIVE RESULTS WHEN RESULTS IS NOT WITHIN THE MEASUREMENT INTERVAL: NA
19. ALERT /CRITICAL VALUES, WHERE APPROPRIATE: NA
20. LABORATORY CLINICAL INTERPRETATION: interpret test result after true positivity of control slide.
21. POTENTIAL SOURCE OF VARIATION: NA
22. REFERENCE: Histopathological laboratory techniques by Culling’s.